Is SAMA or ABBV a better dividend investment in 2026?

SAMA currently yields 18.90% with a 5% 5-year dividend growth rate. ABBV yields 3.67% with 8.9% growth. The better choice depends on your goal: SAMA offers higher current income.

What is the dividend yield difference between SAMA and ABBV?

SAMA has a forward dividend yield of 18.90% ($2.00/share annually). ABBV yields 3.67% ($6.20/share annually). The yield gap is 15.23 percentage points.

Home › Compare › SAMA vs ABBV

SAMA vs ABBV: Dividend Comparison 2026

SAMA yields 18.90% · ABBV yields 3.67%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SAMA wins by $28.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SAMA

● Live price

18.90%

Share price

$10.58

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$68.3K

Annual income

$5,984.15

Full SAMA calculator →

ABBV

AbbVie Inc.

● Live price

3.67%

Share price

$168.90

Annual div

$6.20

5Y div CAGR

8.9%

Payout ratio

58%

After 10 yrs · $10,000 · DRIP

Portfolio value

$39.9K

Annual income

$1,154.43

Full ABBV calculator →

Portfolio growth — SAMA vs ABBV

📍 SAMA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SAMA	ABBV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SAMA + ABBV cover 4 of 12 months — good coverage

Jan

ABBV

Feb

—

Mar

—

Apr

ABBV

May

—

Jun

—

Jul

ABBV

Aug

—

Sep

—

Oct

ABBV

Nov

—

Dec

—

SAMA pays

ABBV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAMA

Annual income on $10K today (after 15% tax)

$1,606.81/yr

After 10yr DRIP, annual income (after tax)

$5,086.53/yr

ABBV

Annual income on $10K today (after 15% tax)

$312.02/yr

After 10yr DRIP, annual income (after tax)

$981.27/yr

At 15% tax rate, SAMA beats the other by $4,105.26/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAMA + ABBV for your $10,000?

SAMA: 50%ABBV: 50%

100% ABBV50/50100% SAMA

Portfolio after 10yr

$54.1K

Annual income

$3,569.29/yr

Blended yield

6.60%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

SAMA

No analyst data

Altman Z

7.1

Piotroski

2/9

ABBV

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$256.15

+51.7% upside vs current

Range: $223.00 — $299.00

Altman Z

2.0

Piotroski

8/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAMA buys

ABBV buys

No recent congressional trades found for SAMA or ABBV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSAMAABBV

Forward yield	18.90% ✓	3.67%
Annual dividend / share	$2.00	$6.20 ✓
Payout ratio	50% ✓	58%
1-year div growth	0%	4.7% ✓
5-year div CAGR	0%	8.9% ✓
Portfolio after 10y	$68.3K ✓	$39.9K
Annual income after 10y	$5,984.15 ✓	$1,154.43
Total dividends collected	$37.7K ✓	$7.2K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SAMA vs ABBV ($10,000, DRIP)

Year	SAMA Portfolio	SAMA Income/yr	ABBV Portfolio	ABBV Income/yr	Gap
1← crossover	$12,590	$1,890.36	$11,520	$399.75	+$1.1K → SAMA
2	$15,696	$2,224.33	$13,261	$450.98	+$2.4K → SAMA
3	$19,386	$2,591.59	$15,255	$508.41	+$4.1K → SAMA
4	$23,735	$2,991.50	$17,536	$572.74	+$6.2K → SAMA
5	$28,819	$3,422.91	$20,145	$644.78	+$8.7K → SAMA
6	$34,721	$3,884.25	$23,126	$725.38	+$11.6K → SAMA
7	$41,525	$4,373.52	$26,532	$815.52	+$15.0K → SAMA
8	$49,320	$4,888.38	$30,420	$916.26	+$18.9K → SAMA
9	$58,199	$5,426.21	$34,855	$1,028.80	+$23.3K → SAMA
10	$68,257	$5,984.15	$39,914	$1,154.43	+$28.3K → SAMA

SAMA vs ABBV: Complete Analysis 2026

SAMA — Stock

Schultze Special Purpose Acquisition Corp. II does not have significant operations. It intends to enter into a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Rye Brook, New York.

Full SAMA Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

📬

Get this SAMA vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAMA vs SCHD SAMA vs JEPI SAMA vs O SAMA vs KO SAMA vs MAIN SAMA vs JNJ SAMA vs MRK SAMA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.